BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 26191242)

  • 41. Long non-coding RNA UBE2CP3 enhances HCC cell secretion of VEGFA and promotes angiogenesis by activating ERK1/2/HIF-1α/VEGFA signalling in hepatocellular carcinoma.
    Lin J; Cao S; Wang Y; Hu Y; Liu H; Li J; Chen J; Li P; Liu J; Wang Q; Zheng L
    J Exp Clin Cancer Res; 2018 Jun; 37(1):113. PubMed ID: 29866133
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum expression and diagnostic potential of long non-coding RNAs NEAT1 and TUG1 in viral hepatitis C and viral hepatitis C-associated hepatocellular carcinoma.
    Mohyeldeen M; Ibrahim S; Shaker O; Helmy H
    Clin Biochem; 2020 Oct; 84():38-44. PubMed ID: 32526227
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long noncoding RNA TPTE2P1 promotes the migration and invasion of hepatocellular carcinoma.
    Liu J; Wang Z; Yin Y; Li N; Ye NY; Bao B; Gu HC
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3733-3741. PubMed ID: 31114999
    [TBL] [Abstract][Full Text] [Related]  

  • 44. NEAT1: A novel cancer-related long non-coding RNA.
    Yu X; Li Z; Zheng H; Chan MT; Wu WK
    Cell Prolif; 2017 Apr; 50(2):. PubMed ID: 28105699
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Downregulation of lncRNA NEAT1_2 radiosensitizes hepatocellular carcinoma cells through regulation of miR-101-3p/WEE1 axis.
    Chen X; Zhang N
    Cell Biol Int; 2019 Jan; 43(1):44-55. PubMed ID: 30488993
    [TBL] [Abstract][Full Text] [Related]  

  • 46. LncRNA CSMD1-1 promotes the progression of Hepatocellular Carcinoma by activating MYC signaling.
    Liu J; Xu R; Mai SJ; Ma YS; Zhang MY; Cao PS; Weng NQ; Wang RQ; Cao D; Wei W; Guo RP; Zhang YJ; Xu L; Chen MS; Zhang HZ; Huang L; Fu D; Wang HY
    Theranostics; 2020; 10(17):7527-7544. PubMed ID: 32685003
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased long noncoding RNA LASP1-AS is critical for hepatocellular carcinoma tumorigenesis via upregulating LASP1.
    Yin L; Chen Y; Zhou Y; Deng G; Han Y; Guo C; Li Y; Zeng S; Shen H
    J Cell Physiol; 2019 Aug; 234(8):13493-13509. PubMed ID: 30677131
    [TBL] [Abstract][Full Text] [Related]  

  • 48. PTBP3 splicing factor promotes hepatocellular carcinoma by destroying the splicing balance of NEAT1 and pre-miR-612.
    Yang X; Qu S; Wang L; Zhang H; Yang Z; Wang J; Dai B; Tao K; Shang R; Liu Z; Li X; Zhang Z; Xia C; Ma B; Liu W; Li H; Dou K
    Oncogene; 2018 Dec; 37(50):6399-6413. PubMed ID: 30068940
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long non-coding RNA NRON is downregulated in HCC and suppresses tumour cell proliferation and metastasis.
    Yao Z; Xiong Z; Li R; Liang H; Jia C; Deng M
    Biomed Pharmacother; 2018 Aug; 104():102-109. PubMed ID: 29772429
    [TBL] [Abstract][Full Text] [Related]  

  • 50. FAM134B induces tumorigenesis and epithelial-to-mesenchymal transition via Akt signaling in hepatocellular carcinoma.
    Zhang ZQ; Chen J; Huang WQ; Ning D; Liu QM; Wang C; Zhang L; Ren L; Chu L; Liang HF; Fan HN; Zhang BX; Chen XP
    Mol Oncol; 2019 Apr; 13(4):792-810. PubMed ID: 30556279
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long noncoding RNA PCAT-1 promotes invasion and metastasis via the miR-129-5p-HMGB1 signaling pathway in hepatocellular carcinoma.
    Zhang D; Cao J; Zhong Q; Zeng L; Cai C; Lei L; Zhang W; Liu F
    Biomed Pharmacother; 2017 Nov; 95():1187-1193. PubMed ID: 28931210
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long non-coding RNA SNHG20 predicts a poor prognosis for HCC and promotes cell invasion by regulating the epithelial-to-mesenchymal transition.
    Liu J; Lu C; Xiao M; Jiang F; Qu L; Ni R
    Biomed Pharmacother; 2017 May; 89():857-863. PubMed ID: 28282787
    [TBL] [Abstract][Full Text] [Related]  

  • 53. mTOR regulates aerobic glycolysis through NEAT1 and nuclear paraspeckle-mediated mechanism in hepatocellular carcinoma.
    Zhang H; Su X; Burley SK; Zheng XFS
    Theranostics; 2022; 12(7):3518-3533. PubMed ID: 35547764
    [No Abstract]   [Full Text] [Related]  

  • 54. Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition.
    Wang TH; Yu CC; Lin YS; Chen TC; Yeh CT; Liang KH; Shieh TM; Chen CY; Hsueh C
    Oncotarget; 2016 Jul; 7(28):43588-43603. PubMed ID: 27248828
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis.
    Wang Y; Liu Z; Yao B; Li Q; Wang L; Wang C; Dou C; Xu M; Liu Q; Tu K
    Mol Cancer; 2017 Jul; 16(1):123. PubMed ID: 28716020
    [TBL] [Abstract][Full Text] [Related]  

  • 56. LncRNA SNHG3 Promotes Hepatocellular Tumorigenesis by Targeting miR-326.
    Zhao Q; Wu C; Wang J; Li X; Fan Y; Gao S; Wang K
    Tohoku J Exp Med; 2019 Sep; 249(1):43-56. PubMed ID: 31548493
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic significance of long non-coding RNA PCAT-1 expression in human hepatocellular carcinoma.
    Yan TH; Yang H; Jiang JH; Lu SW; Peng CX; Que HX; Lu WL; Mao JF
    Int J Clin Exp Pathol; 2015; 8(4):4126-31. PubMed ID: 26097602
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.
    He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S
    J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Overexpression of long non-coding RNA MINCR contributes to progressive clinicopathological features and poor prognosis of human hepatocellular carcinoma.
    Jin XL; Lian JR; Guan YH
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8197-8202. PubMed ID: 30556858
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of HIF1A-AS1 promoted starvation-induced hepatocellular carcinoma cell apoptosis by reducing HIF-1α/mTOR-mediated autophagy.
    Hong F; Gao Y; Li Y; Zheng L; Xu F; Li X
    World J Surg Oncol; 2020 May; 18(1):113. PubMed ID: 32473641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.